ZBIO (Zenas BioPharma) General and Admin. Expense: $57.82 Mil (TTM As of Mar. 2026)


ZBIO Zenas BioPharma Inc ZBIO
12 GF Score
Price $27.28
! 1 Warning Sign
View Full Analysis

What is Zenas BioPharma General and Admin. Expense?

Zenas BioPharma ZBIO -1.30% 12 General and Admin. Expense is $57.82 Mil as of Mar. 2026. GuruFocus rates ZBIO with a GF Score™ of 12/100. The stock has 1 warning sign investors should review.

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. Zenas BioPharma's General and Admin. Expense for the three months ended in Mar. 2026 was $16.91 Mil. Its General and Admin. Expense for the trailing twelve months (TTM) ended in Mar. 2026 was $57.82 Mil.

Zenas BioPharma General and Admin. Expense Related Terms

Zenas BioPharma General and Admin. Expense Historical Data

* Premium members only.

The historical data trend for Zenas BioPharma's General and Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zenas BioPharma General and Admin. Expense Chart

Zenas BioPharma Annual Data
Trend Dec22 Dec23 Dec24 Dec25
General and Admin. Expense
13.51 17.11 29.75 53.32

Zenas BioPharma Quarterly Data
Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
General and Admin. Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.42 12.14 13.18 15.59 16.91
ZBIO
12GF Score
Zenas BioPharma Inc ZBIO
General and Admin. Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zenas BioPharma General and Admin. Expense Calculation

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company.

General and Admin. Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $57.82 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a General and Admin. Expense of $57.82 Mil mean?
Zenas BioPharma (ZBIO) has a General and Admin. Expense of $57.82 Mil as of Mar. 2026. General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. View historical data on Zenas BioPharma and its competitors.
Is Zenas BioPharma's General and Admin. Expense too high?
Zenas BioPharma's current General and Admin. Expense is $57.82 Mil. Overall, Zenas BioPharma has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Zenas BioPharma's General and Admin. Expense compare to AKTS and MLTX?
Zenas BioPharma's General and Admin. Expense of $57.82 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good General and Admin. Expense for a Biotechnology company?
A good General and Admin. Expense depends on the Biotechnology industry context. However, General and Admin. Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high General and Admin. Expense mean?
A high General and Admin. Expense can signal that a stock is expensive relative to its fundamentals. General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. View historical data on Zenas BioPharma and its competitors. Zenas BioPharma's current General and Admin. Expense is $57.82 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zenas BioPharma stock overvalued right now?
Zenas BioPharma (ZBIO) has a current General and Admin. Expense of $57.82 Mil. The current General and Admin. Expense is $57.82 Mil. Zenas BioPharma's overall GF Score™ is 12/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is General and Admin. Expense calculated?
General and Admin. Expense is calculated from a company's financial statements. For Zenas BioPharma (ZBIO), the current General and Admin. Expense is $57.82 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Zenas BioPharma Business Description

Address 852 Winter Street, Suite 250, Waltham, MA, USA, 02451
Zenas BioPharma Inc is a clinical-stage biopharmaceutical company. Its I&I product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcyRIIb, which are present across B cell lineage, in order to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them. The Company manages its operations on a consolidated basis as a single reportable segment focused on the research, development and commercialization of transformative immunology-based therapies.
12GF Score

Get the complete analysis for ZBIO

General and Admin. Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$27.28
Price